RegenxBio Inc. (NASDAQ:RGNX) raised $175.5 million through the sale of 2.7 million shares at $65 in a follow-on underwritten by Morgan Stanley, BofA Merrill Lynch, Barclays and Raymond James.
{iframe}https://www.biocentury.com/bc-extra/financial-news/2018-08-10/regenxbio-raises-1755m-follow{/iframe}